Prokarium benoemt industrieveteraan Thomas Eldered tot voorzitter van de raad van bestuur
LONDEN–(BUSINESS WIRE)– Prokarium, een biofarmaceutisch bedrijf dat baanbrekend werk verricht op het gebied van oncologie van microbiële immunotherapie, heeft vandaag de benoeming aangekondigd van Thomas Eldered als voorzitter van de raad van bestuur. Thomas Eldered volgt Steve Chatfield, PhD, op die lid blijft van de raad van bestuur van Prokarium.
Dit persbericht bevat multimedia. Bekijk de volledige release hier: https://www.businesswire.com/news/home/20211005005314/en/
“Thomas brengt naar Prokarium meer dan 30 jaar leiderschaps- en leidinggevende ervaring in de biofarmaceutische sector, en leidt met succes biotech-innovatie vanaf een vroeg stadium van onderzoek tot commercialisering. In de loop van zijn carrière was hij medeoprichter en bestuurder van Recipharm AB, en groeide het uit tot een van de vijf grootste CDMO’s ter wereld. Als president van Flerie Invest heeft hij geïnvesteerd in bedrijven met ambitieuze wetenschap in de life science-sector”, zegt Kristen Albright, PharmD, Chief Executive Officer van Prokarium. “We zijn zeer verheugd dat we de mogelijkheid hebben om nauw samen te werken met Thomas tijdens de volgende fase van de ontwikkeling van Prokarium.”
Prokarium Appoints Industry Veteran Thomas Eldered as Chairman of the Board
LONDON–(BUSINESS WIRE)– Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Thomas Eldered as Chairman of the Board. Thomas Eldered succeeds Steve Chatfield, PhD, who will remain a Member of Prokarium’s Board of Directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211005005314/en/
Thomas Eldered, Chairman of the Board of Prokarium (Photo: Business Wire)
“Thomas brings to Prokarium over 30 years’ leadership and executive experience in the biopharmaceutical industry, successfully leading biotech innovation from early-stage research through commercialization. Over the course of his career, he co-founded and managed Recipharm AB, growing it into one of the five largest CDMOs in the world. As President of Flerie Invest, he has invested in companies with ambitious science across the life science sector,” said Kristen Albright, PharmD, Chief Executive Officer of Prokarium. “We are thrilled to have the opportunity to work closely with Thomas during the next phase of Prokarium’s development.”
“I am honored to be joining Prokarium’s Board of Directors at this time,” Eldered said. “Prokarium has a compelling data set supporting the advancement of their lead microbial immunotherapy program and is aiming to shift the treatment paradigm for bladder cancer patients. The company is also developing an exciting next-generation Salmonella platform that will target a broad range of cancer indications as a monotherapy or in combination with other advanced immunotherapies.”
Eldered is President of Flerie Invest, which finances venture and growth stage companies engaged in drug development and associated tools or applications tackling major medical challenges. In 1995, Eldered co-founded Recipharm AB and went on to serve as CEO, leading the company through a successful IPO in 2014. Recipharm AB remains among the top five CDMOs in the world and now includes around 30 manufacturing and development facilities in Europe, India, Israel and North America. Eldered received his MSc in Industrial and Management Engineering at Linköping University.
About Prokarium
Prokarium is a biopharmaceutical company pioneering the field of microbial immunotherapy. Our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects. Prokarium is based London, UK. For further information, visit https://www.prokarium.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211005005314/en/
Contacts
For Prokarium
Kristen Albright
Chief Executive Officer
info@prokarium.com
www.prokarium.com
For media
MacDougall Advisors
Matthew Corcoran or Mario Brkulj
+1 781-235-3060 or +49 175 5711 562